[1-(2,5-dimethylphenyl)-2-methylisoquinolin-2-ium-6-yl]-triphenylsilane
C36H32NSi+ — CID 155638155
Data last refreshed: (MolForge compound catalog, from PubChem)
About [1-(2,5-dimethylphenyl)-2-methylisoquinolin-2-ium-6-yl]-triphenylsilane
[1-(2,5-dimethylphenyl)-2-methylisoquinolin-2-ium-6-yl]-triphenylsilane (PubChem CID 155638155) has the molecular formula C36H32NSi+ and a molecular weight of 506.75 g/mol. Its IUPAC name is [1-(2,5-dimethylphenyl)-2-methylisoquinolin-2-ium-6-yl]-triphenylsilane.
Molecular Properties
| Compound Name | [1-(2,5-dimethylphenyl)-2-methylisoquinolin-2-ium-6-yl]-triphenylsilane |
|---|---|
| PubChem CID | 155638155 |
| Molecular Formula | C36H32NSi+ |
| Molecular Weight | 506.75 g/mol |
| Exact Mass | 506.23 |
| IUPAC Name | [1-(2,5-dimethylphenyl)-2-methylisoquinolin-2-ium-6-yl]-triphenylsilane |
| SMILES | Cc1ccc(C)c(-c2c3ccc([Si](c4ccccc4)(c4ccccc4)c4ccccc4)cc3cc[n+]2C)c1 |
| InChI | InChI=1S/C36H32NSi/c1-27-19-20-28(2)35(25-27)36-34-22-21-33(26-29(34)23-24-37(36)3)38(30-13-7-4-8-14-30,31-15-9-5-10-16-31)32-17-11-6-12-18-32/h4-26H,1-3H3/q+1 |
| InChIKey | CXQDMZPMOCGUQB-UHFFFAOYSA-N |
| XLogP | 5.33 |
| TPSA | 3.88 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | |
| Rotatable Bonds | 5 |
| Heavy Atoms | 38 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 506.75 |
| LogP ≤ 5 | 5.33 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 0 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'heavy_metal', 'substructure': 'N/A'}, {'alert_name': 'quaternary_nitrogen_1', 'substructure': 'N/A'}, {'alert_name': 'triphenyl_methyl-silyl', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155638155 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.